# WuXi Advanced Therapies - Inspection Records

Source: https://www.keypedia.com/companies/wuxi-advanced-therapies/2d12016c-2b9d-4b5e-91a8-4f8af5bee2e1

> Inspection records and compliance data for WuXi Advanced Therapies in Philadelphia, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: WuXi Advanced Therapies
- FEI Number: 1000122198
- City: Philadelphia
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 4751 League Island Blvd
- Zip Code: 19112
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - WuXi Advanced Therapies - Unknown Date](https://www.keypedia.com/records/483/wuxi-advanced-therapies/924dfd6d-83e2-4d18-9a4f-183c23595f40) — source: FDA, date: Invalid Date
- [FDA Inspection 1299454 - WuXi Advanced Therapies - 2025-11-25](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/3ea12386-b657-449c-b644-e365d8fe3cee) — source: FDA, date: November 25, 2025
- [FDA Inspection 1299454 - WuXi Advanced Therapies - 2025-11-25](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/1f18cb39-7ccf-4206-9dc5-548c27bdc8b5) — classification: No Action Indicated (NAI), source: FDA, date: November 25, 2025
- [FDA Inspection 1262215 - WuXi Advanced Therapies - 2025-02-07](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/b2abda4e-18e9-4bae-bfb9-d3361e7d2540) — source: FDA, date: February 7, 2025
- [FDA Inspection 1262215 - WuXi Advanced Therapies - 2025-02-07](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/b947c96b-65c6-4ce5-b651-258f5e4a8432) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2025
- [FDA Inspection 1230154 - WuXi Advanced Therapies - 2023-09-01](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/c9716d0d-7be9-4919-9b44-36c3d85cf465) — source: FDA, date: September 1, 2023
- [EIR - WuXi Advanced Therapies - 2020-01-22](https://www.keypedia.com/records/eir/wuxi-advanced-therapies/86920c1f-df84-426f-abfc-b6d5236095a6) — source: FDA, date: January 22, 2020
- [FDA Inspection 1121335 - WuXi Advanced Therapies - 2020-01-22](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/0a449cf5-20ff-4805-b457-1937e3622faa) — classification: No Action Indicated (NAI), source: FDA, date: January 22, 2020
- [EIR - WuXi Advanced Therapies - 2015-04-17](https://www.keypedia.com/records/eir/wuxi-advanced-therapies/901c054b-35c3-4bc7-bd37-82e49a4ef62c) — source: FDA, date: April 17, 2015
- [483 - WuXi Advanced Therapies - 2015-04-17](https://www.keypedia.com/records/483/wuxi-advanced-therapies/edf594f4-4bfa-46a0-be91-60c08c9553ca) — source: FDA, date: April 17, 2015
- [FDA Inspection 921995 - WuXi Advanced Therapies - 2015-04-17](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/c0b6184b-9c4a-43f0-b96a-8c40e321304f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2015
- [FDA Inspection 849366 - WuXi Advanced Therapies - 2013-09-12](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/f08ed46d-0beb-4cdb-895b-6ce430364fc7) — classification: No Action Indicated (NAI), source: FDA, date: September 12, 2013
- [FDA Inspection 796290 - WuXi Advanced Therapies - 2012-08-24](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/4d1ba375-50ca-41f9-a127-bec6710c305a) — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2012
- [FDA Inspection 638036 - WuXi Advanced Therapies - 2010-01-06](https://www.keypedia.com/records/fda_inspections/wuxi-advanced-therapies/1ac35a54-e2db-416d-b7e2-62413b20f6e2) — classification: No Action Indicated (NAI), source: FDA, date: January 6, 2010

## Related Companies

- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg/9c78f7c1-8016-4128-9dc3-ce5b4e0e0d44)
- [MSN Laboratories Private Limited (Formulations Division, Unit-II)](https://www.keypedia.com/companies/msn-laboratories-private-limited-formulations-division-unit-ii/44914049-4b84-4bac-abac-9af09a223eb8)
- [Alcami Carolinas Corporation](https://www.keypedia.com/companies/alcami-carolinas-corporation/87394b03-3fcf-4acb-836a-8c46cc6881c2)
- [Aurobindo Pharma Limited](https://www.keypedia.com/companies/aurobindo-pharma-limited/9bedb5d4-0483-4173-bc76-1c5737a28fc1)
- [Vetter Pharma Fertigung GmbH & Co. KG](https://www.keypedia.com/companies/vetter-pharma-fertigung-gmbh-co-kg/6b51041e-37a7-4672-a7e2-c3c871d6231b)
- [Shiseido America Inc.](https://www.keypedia.com/companies/shiseido-america-inc/612a919a-3309-4649-b8bf-d8cd6af8ed5a)
- [Quotient Sciences - Philadelphia, LLC](https://www.keypedia.com/companies/quotient-sciences-philadelphia-llc/21968347-fe31-4ffc-801c-5253fa909968)
- [Pacira Pharmaceuticals, Inc.](https://www.keypedia.com/companies/pacira-pharmaceuticals-inc/0062419b-850d-4eea-ad5d-918907be2e52)
- [Seqirus Pty Ltd](https://www.keypedia.com/companies/seqirus-pty-ltd/673f8bd1-d8ea-4125-a3cf-a83827b17359)
- [Agnitio Inc](https://www.keypedia.com/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb)

## Related Officers

- [company_representative](https://www.keypedia.com/people/michael-correa/52d11b7e-2372-4052-9998-2ce9a0382d65)
- [Consumer Safety Officer at FDA U.S. Food and Drug Administration](https://www.keypedia.com/people/ko-u-min/9bb5f33e-857b-4c6f-a550-fdb439760e30)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)